Entero Healthcare #entero #enterohealth A company that's consistently growing at 30%+ CAGR on topline and 60%+ CAGR on EBITDA for the last 5 years Solid Q3FY25 🔥 Good margin expansion witnessed QoQ and YoY Solid track record of inorganic acquisition led growth Q3FY25: Rev at 1359cr⏫37% Gross profit at 133cr⏫48% EBITDA at 50cr⏫75% OPM at 3.7% vs 2.9% Q2 EBITDA at 42cr⏫20% QoQ PAT at 29cr vs 7cr⏫322% 9MFY25: Rev at 3757cr⏫30% Gross profit at 356cr⏫37% EBITDA at 123cr⏫48% PAT at 75cr⏫308% New WC days steady at 69 RoCE 12.3% RoE 9% FY21-24E: Revenue CAGR 30% Gross profit CAGR 35% EBITDA CAGR 73% Outperforming market growth IPM growth rate of 8% Entero growth rate at 30% 9MFY25 customers at 86200+ SKUs at 76,600+